Almonds: limited effects on the gut microbiota

Against all expectations, the consumption of almonds seems to have no effect on the gut microbiota and intestinal transit. The only benefit observed: a rise in the level of butyrate which saves the day for the funders of the study.

The almond producers of California have once again treated themselves to the Holy Grail of studies: a randomized controlled trial (RCT). Aim: to evaluate the impact of almonds and of their transformation (ground or not) on intestinal bifidobacteria and, secondarily, on the overall composition of the gut microbiota and intestinal transit time. To do this, 87 adults in good health, avid snackers (crisps, chocolate, etc.) and little inclined to consume fiber (fruit, vegetables, etc.), took part in this 3-arm trial: over 4 weeks, they replaced their 2 usual snacks either by whole almonds (2*23 g/d), or by ground almonds (2+23 g/d) or by 2 muffins with the same calorie content (control).

26 g of almonds = around 20 almonds (1 handful)

Almonds: the end of a nutritional myth?

Outcome? Contrary to the main hypothesis, bifidobacteria were not more abundant in the stools of the whole almond (8.7%) or ground almond (7.8 %) groups compared with the control (13.0 %), the opposite was the case. Nevertheless, the slight difference does not withstand an adjustment to the test. Almonds also have no effect on the gut microbiota, intestinal transit time (which the researchers thought was accelerated), stool consistency or intestinal symptoms. The particle size of ground almonds was finer than that of almonds after mastication: for all that, the effect of grinding on the release of lipids and therefore their accessibility by the organism proved smaller than anticipated, to the point that the researchers concluded that the commercial grinding of almonds does not lead to clinically significant differences in terms of nutrient bioaccessibility.
The only significant difference observed: the consumption of almonds (whole and ground) led to an increase in the production of butyrate by the gut bacteria (24.1 μmol/g vs 18.2 μmol/g for the control), a short-chain fatty acid with recognized health benefits, which, according to the authors would suggest a modification of the functions of the gut microbiota. 

No prebiotic effect 

It is without doubt a disappointment for the American producers but, according to this RCT, the consumption of almonds does not exert a prebiotic effect on the fecal bifidobacteria, produce major changes in the microbiota, or affect transit. Could the predominance of women (86.2%) and young people (27.5 ± 6.2 years) in the volunteers have biased the results? Perhaps. In the meantime, other studies are expected targeting a more uniform population to confirm these results. 

Summary
Off
Sidebar
On
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
News Gastroenterology

Fat, sugar, and metabolic disease: links between the gut microbiota and immunity

We already knew that too much fat and sugar promotes obesity and type 2 diabetes. Now we also know that the gut microbiota and its immune system play a role in regulating the metabolism. Deciphering the mechanisms involved has been no small task, but researchers have recently succeeded in doing so1, revealing the major role played by excessive sugar.

The gut microbiota

It’s all common sense. Often too rich in fat and sugar, the “ (sidenote: Western diet Diet rich in processed foods, refined sugar, salt, saturated fats (red meats) and trans fats (pastries) Zinöcker MK, Lindseth IA. The Western Diet-Microbiome-Host Interaction and Its Role in Metabolic Disease. Nutrients. 2018 Mar 17;10(3):365.  ) diet has an impact on our health. It tends to increase inflammation in the body and to disrupt the metabolism. It can thus lead to obesity, type 2 diabetes, and metabolic syndrome. Numerous studies have shown that the gut microbiota and its immune system play a major role in metabolic balance, with disturbances in the gut converting excess food into extra pounds and serious illnesses.

More fat and sugar means less gut immune cells to balance the metabolism 

To better understand these disturbances, researchers fed mice a diet rich in fat and sugar for four weeks. As expected, in addition to gaining more weight than mice fed normally, these overfed mice also developed a (sidenote: Metabolic syndrome Combination of several metabolic anomalies: high blood pressure, large waist circumference, increased blood triglyceride and glucose levels associated to a low blood level of “good” cholesterol. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome--a new worldwide definition. Lancet. 2005 ; 366 (9491) : 1059-62. ) . An analysis of the mice’s gut flora via their droppings showed that this diet caused a rapid loss of (sidenote: Segmented filamentous bacteria Segmented filamentous bacteria (SFB) are bacteria of the Clostridiaceae family that colonize the gut of many vertebrate and invertebrate animals without causing an inflammatory response. On the contrary, their presence is thought to stimulate the immune response. They help in the differentiation and maturation of certain defense cells and promote the elimination of pathogenic microbes.  Hedblom GA, Reiland HA, Sylte MJ, et al. Segmented filamentous bacteria–metabolism meets immunity. Frontiers in microbiology. 2018 Aug 24;9:1991.  https://www.frontiersin.org/articles/10.3389/fmicb.2018.01991/full   ) . This in turn reduced the production of (sidenote: T helper 17 (Th17) cells Th17 cells are immune system cells that play a role in host defense against pathogens, particularly at epithelial barriers, such as the gut barrier. Awasthi A, Kuchroo VK (2009) Th17 cells: From precursors to players in inflammation and infection. Int Immunol 21:489–498. ) , subsequent to which the metabolic syndrome appeared. 

The researchers found that Th17 cells regulate the absorption of lipids in the gut and are necessary for protection against metabolic syndrome. The loss of Th17 cells is thus to blame for the adverse health effects of a diet high in fat and sugar. By administering segmented filamentous bacteria to the overfed mice, Th17 production was restored. As a result, the mice lost weight and their metabolism improved.

Sugar, the metabolism’s worst enemy 

But which is most to blame, too much fat or too much sugar? The effects of a diet rich in fat and sugar (including sucrose and maltodextrin, common in candy and soda) were compared with those of a diet rich in fat but low in sugar. The researchers found that sugar on its own modifies the composition of the gut microbiota to the detriment of the segmented filamentous bacteria that stimulate Th17 cells. So would it be enough to eliminate sugar from the diet to ensure protection against metabolic disease? Not entirely, according to the researchers, since protection also requires the presence of the Th17 cells produced by the gut microbiota.

In short, metabolic syndrome, obesity, and type 2 diabetes are the result of complex interactions between diet, the gut microbiota, and immunity. According to the researchers, there is no “universal” diet that would produce the desired effect in everyone. Instead, a personalized approach to metabolic disorders is required. In the future, such approaches could take into account inter-individual differences in the gut microbiota’s immune system.

Summary
Off
Sidebar
On
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
News

Does the gut microbiota influence vaccine efficacy?

Some children treated with vaccines fail to develop protective immunity, especially in low- and middle-income countries. The gut microbiota is intimately linked to immune function and may be one of the factors responsible for this variability in vaccine response.

Vaccines are one of the greatest successes of public health, saving millions of lives worldwide, especially among young children (0-5 years), who are more vulnerable to infectious diseases. However, their efficacy varies from one population to another, with higher rates of protective immunity in European countries than in low- and middle-income countries (LMIC). Since the development of the gut microbiota in early life is intimately linked to the maturation of the immune system, and the microbiota of children in LMIC differ significantly from those of European children, researchers reviewed the evidence pointing to the gut microbiota’s role in disparities in vaccine response.

Immunomodulatory properties

A study on vaccines against tuberculosis, tetanus, hepatitis B, and poliomyelitis in Bangladeshi infants found that the presence of certain taxa is correlated with the rate of vaccine response, positively in the case of Actinobacteria, but negatively for Enterobacteriaceae. In addition, interventions to modify the microbiota (prebiotics, probiotics, antibiotics) provide further evidence of its involvement in vaccine response. A 2018 systematic review summarized the results of 26 studies in humans that used probiotics to enhance the efficacy of various vaccines. The review found positive outcomes in half the studies. Conversely, studies investigating the effects of antibiotics found either no improvement or a reduced immune response, which was attributed to disruption of the microbiota.

Two bacterial genera especially involved 

Two bacterial genera seem particularly capable of modulating responses to vaccines. Bifidobacterium and Bacteroides are essential for the development of a healthy microbiota in young children. However, young children can face significant microbiota disruptions (cesarean section, etc.). The effects of the microbiota on vaccine responses appear to be mediated by certain metabolites and/or cellular components, such as short-chain fatty acids, exopolysaccharides, or extracellular vesicles.

Towards a new generation of vaccine strategies

Although the relevant strains and products need to be better characterized, the intricate relationship between the microbiota and vaccine efficacy opens up rich clinical perspectives. This includes new vaccine stimulation therapies able to improve protection for children from LMIC without the use of adjuvants, which are often thought to have adverse side effects.

Summary
Off
Sidebar
On
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
News Pediatrics

Microplastics in takeaway food put gut and oral flora at risk

However well balanced, takeaway food has consequences for our health. The packaging in which takeaway food is served contains microplastics that impact our microbiota.

Plastic takeaway packaging releases microplastics and nanoplastics that may have a significant impact on the gut and oral microbiota.

Harmful effects on humans remain under-investigated

A study carried out in 2020 showed that plastic food containers made from polypropylene (PP), polystyrene (PS), polyethylene (PE), and polyethylene terephthalate (PET) all contain micro- and nanoplastics. Although the harmful effects of these particles on the microbiota have been demonstrated in animals (fish, shrimp, and mice), until now they have been under-investigated in humans.

Researchers analyzed and compared the gut and oral microbiota of 390 Chinese students aged between 18 and 30 who consumed takeaway food served in plastic packaging either frequently (at least three times a week), occasionally (once a week or less), or never. 

The scientists also created three groups of mice which, for five weeks, were given either a solution of microplastics at 5 mg/ml (20 mice), a solution of nanoplastics at 5 mg/ml (20 mice), or a solution of the same nanoplastics but at 2 mg/ml (20 mice). A control group of 15 mice was also established.

Disruption of microbial balance

The results show that consumers of takeaway food in plastic containers more frequently suffer from gut disorders and coughs than those who never consume such food. They also presented a dysbiosis of the gut and oral microbiota with specific bacterial signatures. The gut microbiota of occasional consumers was strongly associated with the presence of Faecalibacterium, while that of heavy consumers was associated with Collinsella. For the oral microbiota, the bacteria most strongly associated with heavy consumers was Thiobacillus.

Significant impact even with smaller particles and at low doses

The study on mice showed that all the animals fed with plastic particles presented a gut dysbiosis when compared to the control group. Changes in the size (i.e. micro- vs. nanoplastics) or quantity (5 mg/ml vs. 2 mg/ml) of the particles ingested had no effect on their impact.

Moreover, the researchers believe that the recurrent cough in takeaway lovers may mean that micro- and nanoplastics are able to migrate from the gut to the lungs, where they accumulate in the airway microbiota, causing a dysbiosis that leads to the cough. Although yet to be confirmed, these results are one more reason to switch to a glass lunch-box.

Summary
Off
Sidebar
On
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
News Gastroenterology

Can the gut microbiota help improve vaccine efficacy?

The gut microbiota differs from one person to another. These differences may explain variations in vaccine efficacy, with children from low- and middle-income countries showing poorer responses. Researchers are looking for ways to modify gut microbiota composition in the hope of addressing this “immune inequality”.

The gut microbiota

In theory, vaccines work on a simple (or fairly simple) principle: they (sidenote: To do this, a harmless fragment of the invader is inoculated into the host so that it develops targeted defenses. When the real pathogen subsequently appears, our defenses are ready to neutralize it.  https://www.who.int/news-room/feature-stories/detail/how-do-vaccines-work ) However, in practice, vaccines do not always work. They save millions of lives each year, especially among young children who are more vulnerable to infectious disease, but they are more effective in European children than in children from low- and middle-income countries (LMIC). Although treated with vaccines, (sidenote: While nearly 100% of Finnish children develop protective immunity in response to rotavirus vaccines, this is the case for only 58% of children in Nicaragua and 46% of children in Bangladesh. Similarly, protection rates for the BCG vaccine range from 0%-51% in African children versus 88%-100% in European children. ) In other words, the army of antibodies that makes up their (sidenote: Innate and adaptive immunity  The human body protects itself using two kinds of defense mechanisms: innate immunity and adaptive immunity. Innate immunity is the first line of defense against disease agents and is an immediate response, while adaptive immunity is delayed but provides lasting protection Janeway CA Jr, Travers P, Walport M, et al. Immunobiology: The Immune System in Health and Disease. 5th edition. New York: Garland Science; 2001. Principles of innate and adaptive immunity. ) fails to respond. Untrained to recognize and eradicate the enemy, they are unlikely to be able to defend the host in a real battle. But what causes this “immune inequality”?

Gut microbiota, an ally of immune response

The answer may involve a special third force allied with the immune army, the gut microbiota. The development and functioning of the gut microbiota and immune system are intimately linked; but the gut microbiota of European children differs significantly from that of children from LMIC. The researchers thus believe that differences in microbiota composition may explain variations in vaccine response. Accordingly, certain studies have sought to modify the gut microbiota in order to improve immune response. Trials in humans that used probiotics (live bacteria that strengthen the microbiota) to increase the proportion of patients who develop protective immunity have shown positive outcomes in half of cases. Two sentries of the gut microbiota, the bacterial genera (sidenote: Bifidobacterium A genus of Y-shaped bacteria, most species of which are beneficial to humans. They are found in the gut of humans, and in some yogurts.

They:
- Protect the gut barrier 
- Participate in the development of the immune system and help fight inflammation 
- Promote digestion and improve symptoms of gastrointestinal disorders Sung V, D'Amico F, Cabana MD, et alLactobacillus reuteri to Treat Infant Colic: A Meta-analysis. Pediatrics. 2018 Jan;141(1):e20171811.  O'Callaghan A, van Sinderen D. Bifidobacteria and Their Role as Members of the Human Gut Microbiota. Front Microbiol. 2016 Jun 15;7:925. Ruiz L, Delgado S, Ruas-Madiedo P, et al. Bifidobacteria and Their Molecular Communication with the Immune System. Front Microbiol. 2017 Dec 4;8:2345.
)
and Bacteroides, seem particularly capable of rallying the immune system’s troops.

Improving vaccine response

Although further research is required, the researchers are already considering new vaccine strategies that involve the modulation of gut flora composition in the hope of stimulating responses to vaccines. This new approach may increase access to effective vaccines in low- and middle-income countries (LMIC). It may also make it possible to do without certain adjuvants that are added to boost immune responses, but which are thought to have adverse side effects that fuel vaccine hesitancy.

Sources

Jordan A, Carding SR, Hall LJ. The early-life gut microbiome and vaccine efficacy. Lancet Microbe. 2022 Oct;3(10):e787-e794. doi: 10.1016/S2666-5247(22)00185-9.

Summary
Off
Sidebar
On
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
News

Microplastics: beware of takeaway food packaging and their impact on the microbiota!

A study by Chinese researchers suggests that plastic particles from takeaway food packaging may alter the gut and oral microbiota.

The gut microbiota

Only half an hour to eat? Think twice before grabbing fried noodles at your local snack bar... especially if they come in plastic packaging. According to a recent study, the microplastics and nanoplastics in these disposable containers may disrupt your gut and oral microbiota.1

Microplastics and nanoplastics are everywhere!

Resistant, light, cheap... plastic has many advantages. However, plastic can degrade, generating tiny particles that disperse through the air and water, into animals’ bodies, and ultimately into our own bodies via our plates. Microplastics measure less than 5 mm and can be found throughout the body, including in the lungs, placenta, and blood. On the other hand, nanoplastics are not well studied, since they measure less than 100 nm (500 times less than the thickness of a human hair) and are more difficult to detect. Although little is known about their effects on humans, they are still a cause for concern. Not only can they cross the body’s biological barriers, but the additives they contain, considered chemical pollutants, may promote illnesses such as cancer and some forms of inflammatory bowel disease (IBD).2,3

Microbiota imbalance: plastic in the dock

We know that takeaway food packaging releases significant amounts of small plastic particles. Tests on animals fed with these micro- and nanoplastics show an adverse impact on the animals’ gut microbiota. But how do they affect human health?

To answer this question, researchers enrolled 390 Chinese students aged between 18 and 30 and put them into three groups: heavy consumers of takeaway food in plastic packaging (at least three times per week), occasional consumers (maximum once per week), and non-consumers. They collected stool and saliva samples in order to analyze and compare their oral and gut microbiota.

Significant impact on balance of gut and oral flora

The results show that consumers of takeaway food in plastic containers suffer more gut disorders and cough than those who never consume such food. More worryingly, they show significant alterations ( (sidenote: Dysbiosis Generally defined as an alteration in the composition and function of the microbiota caused by a combination of environmental and individual-specific factors. Levy M, Kolodziejczyk AA, Thaiss CA, et al. Dysbiosis and the immune system. Nat Rev Immunol. 2017;17(4):219-232.   ) ) in their gut and oral microbiota. These have specific bacterial signatures, such as higher quantities of Collinsella in their stools and higher quantities of Thiobacillus (previously found in rice fields polluted by plastic) in their mouths.

Opening simple plastic package is far from harmless

A study by Australian researchers4 has shown that cutting, tearing, twisting, or simply handling a piece of adhesive tape, a chocolate wrapper, or a shopping bag may release potentially toxic microplastics. The study has shown that, depending on the type of the packaging and the opening technique, between 0.46 and 250 microplastic particles are released for every centimeter cut, torn, or twisted.

Particles able to pass between body compartments?

The authors suggest that coughing, which was more frequent in the takeaway food eaters, may result from micro- and nanoplastics that migrate from the gut to the lungs, where they accumulate in the airway microbiota, leading to dysbiosis

These results have yet to be confirmed, but in the meantime, consider preparing your own snacks and, above all, carry them in a (more stable) glass container.

Summary
Off
Sidebar
On
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
News

Can gut bacteria and metabolites help the earlier prediction of necrotizing enterocolitis in newborns?

Could certain gut bacteria and three short-chain fatty acids provide a simple, reliable, and early prediction method for neonatal necrotizing enterocolitis? So suggests a study involving 34 premature babies.

NEC

Identify early and intervene as soon as possible. This is the key to managing neonatal necrotizing enterocolitis (NEC), which affects between 5% and 12% of premature babies. However, due to a lack of sufficiently sensitive biomarkers in newborns, this remains wishful thinking. Nonetheless, previous studies have shown the appearance of a gut dysbiosis in the 7 days to 72 hours preceding NEC. Can the microbiota and its metabolites – particularly short-chain fatty acids (SCFAs) involved in maintaining the integrity of the intestinal epithelium – predict NEC?

34 preterm infants with digestive disorders

To explore the predictive value of the gut microbiota and SCFAs, a prospective study was conducted in 34 preterm infants (gestational age less than 34 weeks) suffering from gut disorders (bloating, vomiting, or bloody stools). 17 of the infants were suspected of having NEC and 17 were matched controls without NEC whose stools were collected on the enrollment day. Of the 17 infants suspected of having NEC, (sidenote: Gut perforation The remaining 5 children showed gut perforation on the day of enrollment in the study. ) (a subgroup of the original matched sample), whose stool was collected seven days later on average.

5% and 12% of premature babies Between 5% and 12% of premature babies develop necrotizing enterocolitis (NEC)

20%-30% of infants In 20%-30% of infants this results in death.

Gut dysbiosis precedes NEC

Contrary to the results of previous studies, the researchers did not systematically observe a loss of gut diversity prior to the disease: some indices of bacterial richness (Ace and Chao1) showed a significant difference, while others (Simpson and Shannon) did not. According to the authors, the digestive disorders present in all children in the study (including the controls) may explain this discrepancy with the data from the literature.

Conversely, seven days before the onset of NEC, a change in the composition of the flora was noted: the bacterial species Streptococcus salivarius and Rothia mucilaginosa increased, while Bifidobacterium subsp. lactis decreased. Variations at phylum level (increase in Proteobacteria, decrease in Firmicutes, Actinobacteriota, and Bacteroidota) were also explored, but the differences were not deemed significant.

Three SCFAs as metabolic markers

The researchers also looked at bacterial metabolites, specifically acetate, propionate, and butyrate, which represent 90%-95% of total SCFAs in the human gut. The study showed that these three SCFAs decreased significantly seven days before the onset of NEC, probably due to the decrease in Firmicutes and Bacteroidota. These metabolites proved to be much better predictive biomarkers for NEC than the bacterial biomarkers. More specific and sensitive (AUC of 68%-73%, depending on the SCFA), in the future they may have a clinical application.

Summary
Off
Sidebar
On
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
News Pediatrics Gastroenterology

Exposure to air pollution disturbs the microbiota of babies

Would going green protect our children from lung and cardiovascular diseases?
According to a study published in Gut Microbes, air pollution significantly alters the microbiota of babies, potentially impacting their future health.

The gut microbiota The pulmonary microbiota
Exposure to air pollution disturbs the microbiota of babies

Road transport, factories, wood heating... It has long been known that air pollution adversely affects lung and cardiovascular health. Indeed, recent studies have shown that it alters the microbiota of adults. But what impact do air pollutants have on the microbiota of babies?

To answer this question, scientists from the University of Colorado Boulder (USA) measured air pollutant exposure levels in 103 Californian children aged six months. They also collected stool samples to analyze the composition of their microbiota.

9 out of 10 people According to the WHO, 9 out of 10 people breathe polluted air.

7 million This pollution is responsible for 7 million deaths each year.

Serious microbiota disturbances

The scientists found that, after adjusting for potential confounders such as birthweight, socioeconomic status, mode of delivery, and breast or formula feeding, the more newborns are exposed to air pollution, the greater the changes to the composition of their microbiota.

Air pollution: a major public health issue

Residential heating, road transport, construction sites, industry, and quarries are the main sources of air pollution. They are responsible for emissions of toxic particulate matter (PM) and nitrogen dioxide (NO2). Fine particles can pass through the body’s protective membranes and affect the heart, lungs, and brain. 

Children are particularly sensitive to air pollution. Among children, air pollution can lead to respiratory diseases, cancer, and cognitive disorders.

The microbiota of the most exposed babies contained more Dialister and Dorea, two bacterial genera associated, in adults, with systemic inflammation and a higher risk of cancer, multiple sclerosis, and mental health disorders.

Their microbiota also contained fewer bacteria that produce short-chain fatty acids ( (sidenote: AGCC Acides gras à chaîne courte ) ), which are known to have beneficial effects on gut barrier integrity, cardiovascular health, gut-brain communication, and the (sidenote: Blood-brain barrier The blood-brain barrier is a “physical” barrier that separates the central nervous system (CNS) from the bloodstream. It tightly controls exchanges between the blood and the brain compartment. 
Engelhard HH, Arnone GD, Mehta AI, Nicholas MK. Biology of the blood-brain and blood-brain tumor barriers. InHandbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy 2018 Jan 1 (pp. 113-125). Academic Press. https://www.sciencedirect.com/science/article/pii/B9780128121009000085
)

Understanding the effects of pollution on microbial communities

This study highlights for the first time an association between exposure to ambient air pollution and the gut flora composition of young children. Although concerning, these results still need to be confirmed and completed by further studies. As a next step, researchers should follow changes in the children’s microbiota over time, try to identify the mechanisms by which pollution exerts its effects on microbial communities, and find out whether the changes are really associated with health problems.

Gut microbiota: why is it that important for your health?

Learn more
Summary
Off
Sidebar
On
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
News

Your IBS Diagnosis Check List

How many patients suffering from gut disorder do you see per week? How many are diagnosed with Irritable Bowel Syndrome (IBS)? Do you know that some patients have struggle more than 4 years before receiving a formal medical diagnosis of IBS?

Up to 75% of individuals with Irritable Bowel Syndrome (IBS) may be undiagnosed. Properly diagnosing IBS can be challenging and uncertain, it is a complex disease which is difficult to explain to your patient during an average consultation.

Therefore, Pr. Jean-Marc Sabaté, Pr. Jan Tack, Dr. Pedro Costa Moreira and the Biocodex Microbiota Institute have created a check list tool in order to better diagnose IBS and communicate with your patient. This IBS tool has received the endorsement of the World Gastroenterology Organisation.

IBS
Actu GP : La dysbiose vaginale à l’origine de certains cas d’infertilité ?

Download your tool here:

Image
IBS Diagnostic Tool Pr. J Tack EN

52% Just 1 in 2 people having suffered from a digestive condition involving the microbiota had made the connection

What you will find in the IBS diagnosis tool?

Dear healthcare professionnal, for the first time you will find all the information you need in one usefull IBS diagnosis tool:

  • Simple figures to explain the disease, the symptoms and the pathophysiology
  • The diagnosis criteria and the IBS subtypes
  • A check list of red flags to be investigated to help you confirm your diagnosis
  • The list of investigations that are needed, the one recommended in specific case and finally those not useful as routine test
  • The four general management concepts
  • A frequency proposal to conduct the follow up care

How to define Irritable Bowel Syndrome (IBS)?

What do we know about the pathophysiology?

How to make a confident diagnosis?

Which investigations are needed?

What are the warning signs to be excluded?

What are the general management concepts?

When to schedule a follow-up care?

Endorsed by

The World Gastroenterology Organisation

The World Gastroenterology Organisation (WGO) is a federation of 119 Member Societies and four Regional Associations of gastroenterology representing over 60,000 individual members worldwide. The WGO focuses on the improvement of standards in training, education, and the practice of Gastroenterology, Hepatology and other related disciplines worldwide. https://www.worldgastroenterology.org/

The APSSII

The APSSII is an association of patients suffering from irritable bowel syndrome (IBS, also called functional colopathy). Its purpose is to inform about the disease, to promote research, and to allow patients to come out of isolation.

https://www.apssii.org/accueil/index.php

secretariat@apssii.org 

https://youtu.be/xveUZuPcjak

Get the official printed tool! 

Ask your local representative to get your fan deck brochure of the IBS diagnosis tool. 

To know more

Everything you need to know about Irritable Bowel Syndrome (IBS)

Exclusive materials dedicated to Irritable Bowel Syndrome (IBS)

Recommended by our community

"As a gastroenterologist I’ve never found difficult to diagnose IBS, which is by far the most common intestinal disorder at any age.
But any tool which can help physicians( especially GPs) to reach a correct diagnosis is obviously very welcome."
 -  Mario Guslandi (From Biocodex Microbiota Institute on LinkedIn)

"Excellent, thanks!" - Carlos Mora (From Biocodex Microbiota Institute on LinkedIn)

Sources

1. Barbara G, Grover M, Bercik P, et al. Rome Foundation Working Team Report on Post-Infection Irritable Bowel Syndrome. Gastroenterology. 2019;156(1):46-58.e7.

2. Black CJ, Ford AC. Global burden of irritable bowel syndrome: trends, predictions and risk factors. Nat Rev Gastroenterol Hepatol 2020; 17: 473-86.

3. Blake MR, Raker JM, Whelan K. Validity and reliability of the Bristol Stool Form Scale in healthy adults and patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther. 2016;44(7):693-703.

4. Carbone F, Van den Houte K, Besard L, et al. Diet or medication in primary care patients with IBS: the DOMINO study - a randomised trial supported by the Belgian Health Care Knowledge Centre (KCE Trials Programme) and the Rome Foundation Research Institute [published online ahead of print, 2022 Apr 28]. Gut. 2022;gutjnl-2021-325821.

5. Collins, S. A role for the gut microbiota in IBS. Nat Rev Gastroenterol Hepatol 11, 497–505 (2014).

6. Drossman DA, Tack J. Rome Foundation Clinical Diagnostic Criteria for Disorders of Gut-Brain Interaction. Gastroenterology. 2022 Mar;162(3):675-679

7. Ford AC, Sperber AD, Corsetti M, et al. Irritable bowel syndrome. Lancet. 2020 Nov 21;396(10263):1675-1688.

8. Fukudo S, Okumura T, Inamori M, et al. Evidence-based clinical practice guidelines for irritable bowel syndrome 2020. J Gastroenterol. 2021;56(3):193-217.

9. Hillestad EMR, van der Meeren A, Nagaraja BH, et al. Gut bless you: The microbiota-gut-brain axis in irritable bowel syndrome. World J Gastroenterol. 2022 Jan 28;28(4):412-431.

10. https://www.snfge.org/content/constipation-chronique

11. Kindt S, Louis H, De Schepper H, et al. Belgian consensus on irritable bowel syndrome. Acta Gastroenterol Belg. 2022;85(2):360-382.

12. Lacy BE, Pimentel M, Brenner DM, et al. ACG Clinical Guideline: Management of Irritable Bowel Syndrome. Am J Gastroenterol. 2021;116(1):17-44.

13. Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders [published correction appears in Gastroenterology. 2006 Aug;131(2):688]. Gastroenterology. 2006;130(5):1480-1491.

14. Mearin F, Lacy BE, Chang L, et al. Bowel Disorders. Gastroenterology. 2016;S0016-5085(16)00222-5.

15. Moayyedi P, Mearin F, Azpiroz F, et al. Irritable bowel syndrome diagnosis and management: A simplified algorithm for clinical practice. United European Gastroenterol J. 2017;5(6):773-788.

16. Savarino E, Zingone F, Barberio B, et al. Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility. United European Gastroenterol J. 2022;10(6):556-584.

17. Sayuk GS, Wolf R, Chang L. Comparison of Symptoms, Healthcare Utilization, and Treatment in Diagnosed and Undiagnosed Individuals With Diarrhea-Predominant Irritable Bowel Syndrome. Am J Gastroenterol. 2017 Jun;112(6):892-899.

18. Simrén, M., Tack, J. New treatments and therapeutic targets for IBS and other functional bowel disorders. Nat Rev Gastroenterol Hepatol 15, 589–605 (2018).

19. Sperber AD, Bangdiwala SI, Drossman DA, et al. Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study. Gastroenterology. 2021;160(1):99-114.e3.

20. Sperber AD. Epidemiology and Burden of Irritable Bowel Syndrome: An International Perspective. Gastroenterol Clin North Am. 2021 Sep;50(3):489-503.

21. Vasant DH, Paine PA, Black CJ, et al. British Society of Gastroenterology guidelines on the management of irritable bowel syndrome. Gut. 2021;70(7):1214-1240.

Summary
Off
Sidebar
Off
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
Article Gastroenterology

Everything you need to know about Irritable Bowel Syndrome (IBS)

Accrediting training, infographics, expert’s video, thematic folder, news… Biocodex Microbiota Institute provides you exclusive materials dedicated to Irritable Bowel Syndrome (IBS). Tailor-made tools and contents to improve your daily practice and be(come) easily an IBS expert!

Follow the guide.

IBS

Get your IBS Diagnosis Check List

Your IBS Diagnosis Check List

Properly diagnosing IBS can be challenging and uncertain, it is a complex disea…

Infographic to share with your patients

What is the Irritable Bowel Syndrome (IBS)?

Useful documents

An exhaustive thematic folder about Irritable Bowel Syndrome (IBS)

Functional gastrointestinal disorders from childhood to adulthood

Functional gastrointestinal disorders (FGIDs) have long remained underacknowled…

An accrediting training on IBS

Xpeer course: Gut microbiota in the management of gastrointestinal symptoms

A great opportunity for HCPs to be certified on IBS!

Exclusive Microbiota Magazine content

Plausibility of a pathophysiological role for altered gut microbiota in the irritable bowel syndrome

The most common functional bowel disorder, the irritable bowel syndrome (IBS), …

Microbiota gut-brain axis in Irritable Bowel Syndrome

Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder charac…

 

Latest news about IBS

Patients stories

Living with irritable bowel syndrome (IBS)

Go on the lay public section to discover them
Summary
On
Sidebar
Off
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
Article Gastroenterology